These pathways are leiomyosarcoma-relevant, given that leiomyosarcomas are characterized by a high frequency of alterations in tumor suppressor gene RB1, which negatively regulates transcription factor E2F1 (18). Here, RB1 is linked to leiomyosarcoma.